20h
MarketBeat on MSNGilead Sciences: 4 Reasons This Stock Has Much More To RiseCompanyOverview|NASDAQ:GILD] Gilead Sciences Inc. (NASDAQ: GILD) stock surged to a new 52-week high at $106.69 recently on ...
Gilead currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Just Released: Zacks Top 10 Stocks for 2025 Hurry – you can ...
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Headquartered in Foster City, CA, Gilead Sciences is a pioneer in developing drugs for the treatment of human ...
Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style. Gilead has a Value Score of A.
with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.13% upward. As of now, Gilead Sciences holds a Zacks ...
(RTTNews) - Gilead Sciences Inc. (GILD ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Gilead appears a compelling earnings-beat candidate. However, investors should pay ...
Shares of Gilead Sciences (NASDAQ: GILD) were jumping 7.9% higher on Wednesday at 11:34 a.m. The solid gain came after the big biotech company announced its 2024 fourth-quarter and full-year ...
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Gilead Sciences (GILD) and Alnylam Pharmaceuticals (ALNY). But which of these two ...
In early trading on Wednesday, shares of Gilead Sciences topped the list of the day's best performing components of the Nasdaq 100 index, trading up 8.0%. Year to date, Gilead Sciences registers a ...
with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 2.33% higher. As of now, Gilead Sciences holds a Zacks Rank ...
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Headquartered in Foster City, CA, Gilead Sciences is a pioneer in developing drugs for the treatment of human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results